Literature DB >> 26987792

Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation.

Takeshi Soeki1, Tomomi Matsuura2, Sachiko Bando2, Takeshi Tobiume2, Etsuko Uematsu2, Takayuki Ise2, Kenya Kusunose2, Koji Yamaguchi2, Shusuke Yagi2, Daiju Fukuda2, Hirotsugu Yamada2, Tetsuzo Wakatsuki2, Michio Shimabukuro3, Masataka Sata2.   

Abstract

BACKGROUND: The underlying mechanism of atrial substrate remodeling in atrial fibrillation (AF) remains unknown. In this study, we investigated whether local and systemic levels of microRNA (miR) might be associated with the presence of AF and with left atrial (LA) substrate properties.
METHODS: Blood from the periphery, pulmonary vein (PV), and left atrial appendage (LAA) was sampled from 30 patients with AF undergoing PV isolation, and from 10 control subjects with Wolff-Parkinson-White syndrome and without AF. We measured peripheral, PV, and LAA plasma levels of miR-1, -26, -133a, -328, and -590 by reverse transcription-polymerase chain reaction. LA global contact mapping during sinus rhythm was performed before PV isolation.
RESULTS: Plasma levels of miR-328 were higher in patients with AF than in control subjects. Plasma miR-328 levels were significantly higher in the LAA than in the periphery and PV in patients with AF, but not in control subjects. Plasma miR-1 levels were also higher in the LAA than in the PV in AF patients. Interestingly, LAA plasma levels of miR-328 showed a positive correlation with the LA voltage zone index (area with voltage <0.5mV divided by total LA surface area) and a weak correlation with LA volume.
CONCLUSION: Local production of miR-328 in the left atrium may be involved in the process of atrial remodeling in patients with AF.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Left atrium; MicroRNA; Remodeling; Substrate

Mesh:

Substances:

Year:  2016        PMID: 26987792     DOI: 10.1016/j.jjcc.2015.12.007

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  16 in total

1.  MicroRNA expression signatures of atrial fibrillation: The critical systematic review and bioinformatics analysis.

Authors:  Nan-Nan Shen; Chi Zhang; Zheng Li; Ling-Cong Kong; Xin-Hua Wang; Zhi-Chun Gu; Jia-Liang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-25

2.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

Review 3.  MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.

Authors:  Nicoline W E van den Berg; Makiri Kawasaki; Wouter R Berger; Jolien Neefs; Eva Meulendijks; Anke J Tijsen; Joris R de Groot
Journal:  Cardiovasc Drugs Ther       Date:  2017-06       Impact factor: 3.727

Review 4.  Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.

Authors:  Ananília Medeiros Gomes da Silva; Jéssica Nayara Góes de Araújo; Renata Caroline Costa de Freitas; Vivian Nogueira Silbiger
Journal:  Biomed Res Int       Date:  2017-03-02       Impact factor: 3.411

5.  Dynamic Regulation of Circulating microRNAs During Acute Exercise and Long-Term Exercise Training in Basketball Athletes.

Authors:  Yongqin Li; Mengchao Yao; Qiulian Zhou; Yan Cheng; Lin Che; Jiahong Xu; Junjie Xiao; Zhongming Shen; Yihua Bei
Journal:  Front Physiol       Date:  2018-03-26       Impact factor: 4.566

6.  Downregulation of miRNA‑328 promotes the angiogenesis of HUVECs by regulating the PIM1 and AKT/mTOR signaling pathway under high glucose and low serum condition.

Authors:  Yan Zou; Fei Wu; Qi Liu; Xian Deng; Rui Hai; Xuemei He; Xiangyu Zhou
Journal:  Mol Med Rep       Date:  2020-05-12       Impact factor: 2.952

Review 7.  The Therapeutic Potential of MicroRNAs in Atrial Fibrillation.

Authors:  Xiaona Xu; Zhiqiang Zhao; Guangping Li
Journal:  Mediators Inflamm       Date:  2020-03-12       Impact factor: 4.711

8.  Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Allan Bohm; Lubos Urban; Lubomira Tothova; Ljuba Bacharova; Peter Musil; Jan Kyselovic; Peter Michalek; Tomas Uher; Branislav Bezak; Peter Olejnik; Robert Hatala
Journal:  J Interv Card Electrophysiol       Date:  2021-03-10       Impact factor: 1.900

Review 9.  Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress.

Authors:  Md Sayed Ali Sheikh; Umme Salma; Baohai Zhang; Jimei Chen; Jian Zhuang; Zhu Ping
Journal:  Oxid Med Cell Longev       Date:  2016-06-09       Impact factor: 6.543

10.  Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly.

Authors:  Nana He; Yue Lin Zhang; Yue Zhang; Beili Feng; Zaixing Zheng; Dongjuan Wang; Shun Zhang; Qi Guo; Honghua Ye
Journal:  Front Genet       Date:  2020-03-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.